0001415889-12-000626.txt : 20120501 0001415889-12-000626.hdr.sgml : 20120501 20120501161520 ACCESSION NUMBER: 0001415889-12-000626 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120427 FILED AS OF DATE: 20120501 DATE AS OF CHANGE: 20120501 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MOONEY PATRICK T CENTRAL INDEX KEY: 0001278255 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35218 FILM NUMBER: 12800837 MAIL ADDRESS: STREET 1: C/O SONTRA MEDICAL CORPORATION STREET 2: 10 FORGE PARKWAY CITY: FRANKLIN STATE: MA ZIP: 02038 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Echo Therapeutics, Inc. CENTRAL INDEX KEY: 0001031927 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 411649949 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8 PENN CENTER STREET 2: 1628 JFK BLVD, SUITE 300 CITY: PHILADELPHIA STATE: PA ZIP: 19103 BUSINESS PHONE: 215-717-4100 MAIL ADDRESS: STREET 1: 8 PENN CENTER STREET 2: 1628 JFK BLVD, SUITE 300 CITY: PHILADELPHIA STATE: PA ZIP: 19103 FORMER COMPANY: FORMER CONFORMED NAME: SONTRA MEDICAL CORP DATE OF NAME CHANGE: 20020702 FORMER COMPANY: FORMER CONFORMED NAME: CHOICETEL COMMUNICATIONS INC/MN/ DATE OF NAME CHANGE: 20020701 FORMER COMPANY: FORMER CONFORMED NAME: SONTRA MEDICAL CORP DATE OF NAME CHANGE: 20020701 4 1 form4-05012012_040510.xml X0305 4 2012-04-27 0001031927 Echo Therapeutics, Inc. ECTE 0001278255 MOONEY PATRICK T 8 PENN CENTER 1628 JFK BLVD, SUITE 300 PHILADELPHIA PA 19103 true true false false CEO AND PRESIDENT Common Stock 2012-04-27 4 A 0 150000 0.00 A 2500907 D In accordance with a Restricted Stock Agreement dated April 27, 2012, 25% of the Shares shall vest on each of April 27, 2013, April 27, 2014, April 27, 2015 and April 27, 2016. Notwithstanding the foregoing, (i) all unvested shares shall become fully vested at any earlier time set forth in the Reporting Person's Employment or Change in Control Agreement with the Company (if any) and (ii) all unvested shares shall immediately vest upon the sale of all or substantially all of the assets of the Company or all or substantially all of the outstanding capital stock of the Company in exchange for Liquid Proceeds. As used herein, "Liquid Proceeds" shall mean (a) cash; (b) securities which can be sold immediately on NYSE or NASDAQ; (c) securities which are or will be registered such that they can be sold on NYSE or NASDAQ upon termination of a lock-up period not to exceed 180 days; or (d) or a combination of cash and the foregoing securities. /s/ Kimberly A. Burke, Attorney-in-Fact 2012-05-01